Literature DB >> 17226743

Vascular dementia: emerging trends.

Neelum T Aggarwal1, Charles Decarli.   

Abstract

Vascular dementia is a term used to describe a constellation of cognitive and functional impairment that can be viewed as a subset of the larger syndrome of vascular cognitive impairment associated with cerebrovascular brain injury. Vascular dementia is a common disorder among the elderly, although it can also occur in younger persons. Comprising 20% of all cases of dementia in the United States, vascular dementia is the second most common form of dementia after Alzheimer's disease. Patients with vascular dementia often exhibit mood and behavioral changes and may have focal neurological signs on neurological examination. Primary treatment is through primary or secondary modification of cerebrovascular risk factors such as hypertension, although symptomatic treatments with cholinesterase inhibitors have shown modest symptomatic benefit.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17226743     DOI: 10.1055/s-2006-956757

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  16 in total

Review 1.  Huperzine A for vascular dementia.

Authors:  Zilong Hao; Ming Liu; Zhiqin Liu; Donghao Lv
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15

Review 2.  Is apolipoprotein E4 an important risk factor for vascular dementia?

Authors:  Troy T Rohn
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

Review 3.  The vascular contribution to Alzheimer's disease.

Authors:  Robin Altman; John C Rutledge
Journal:  Clin Sci (Lond)       Date:  2010-08-05       Impact factor: 6.124

4.  CDK5 knockdown prevents hippocampal degeneration and cognitive dysfunction produced by cerebral ischemia.

Authors:  Johana A Gutiérrez-Vargas; Alejandro Múnera; Gloria P Cardona-Gómez
Journal:  J Cereb Blood Flow Metab       Date:  2015-06-24       Impact factor: 6.200

5.  NADPH oxidase 1, a novel molecular source of ROS in hippocampal neuronal death in vascular dementia.

Authors:  Dong-Hee Choi; Kyoung-Hee Lee; Ji-Hye Kim; Ju-Ha Seo; Hahn Young Kim; Chan Young Shin; Jung-Soo Han; Seol-Heui Han; Yoon-Seong Kim; Jongmin Lee
Journal:  Antioxid Redox Signal       Date:  2014-02-06       Impact factor: 8.401

Review 6.  The appropriate use of neuroimaging in the diagnostic work-up of dementia: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2014-02-01

7.  Prevention of Hippocampal Neuronal Damage and Cognitive Function Deficits in Vascular Dementia by Dextromethorphan.

Authors:  Xiaofeng Xu; Bin Zhang; Kaili Lu; Jiangshan Deng; Fei Zhao; Bing-Qiao Zhao; Yuwu Zhao
Journal:  Mol Neurobiol       Date:  2016-02-18       Impact factor: 5.590

8.  Apolipoprotein E pathology in vascular dementia.

Authors:  Troy T Rohn; Ryan J Day; Colin B Sheffield; Alexander J Rajic; Wayne W Poon
Journal:  Int J Clin Exp Pathol       Date:  2014-02-15

9.  Clinical features and multidisciplinary approaches to dementia care.

Authors:  Jacob Hg Grand; Sienna Caspar; Stuart Ws Macdonald
Journal:  J Multidiscip Healthc       Date:  2011-05-15

10.  Cerebrolysin for vascular dementia.

Authors:  Shuhui Cui; Ning Chen; Mi Yang; Jian Guo; Muke Zhou; Cairong Zhu; Li He
Journal:  Cochrane Database Syst Rev       Date:  2019-11-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.